Total assets · 2019–2025

Keros Therapeutics total assets

$338M−45.1% · FY2025

Keros Therapeutics (KROS) reported $338M in total assets for fiscal 2025, −45.1% year on year.

$11.0M2019$269M2020$255M2021$307M2022$370M2023$616M2024$338M2025
Keros Therapeutics — Total assets, 2019–2025
Fiscal yearTotal assetsChangeFiling
FY20252025-12-31$338M−45.1%Open →
FY20242024-12-31$616M+66.4%Open →
FY20232023-12-31$370M+20.6%Open →
FY20222022-12-31$307M+20.2%Open →
FY20212021-12-31$255M−5.3%Open →
FY20202020-12-31$269M+2,359.5%Open →
FY20192019-12-31$11.0M—Open →

Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +77.1%

Total assets at companies of similar size

Full ranking by total assets →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Keros Therapeutics total assets |url=https://companiesranked.com/en/company/keros-therapeutics/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Keros Therapeutics total assets. CompaniesRanked. https://companiesranked.com/en/company/keros-therapeutics/total-assets

BibTeX

@misc{companiesranked-en-company-keros-therapeutics-total-assets-2026,
  author       = {{CompaniesRanked}},
  title        = {{Keros Therapeutics total assets}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/keros-therapeutics/total-assets}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001664710-26-000049 · August 3, 2026

{{cite web |title=Keros Therapeutics total assets — 10-Q (0001664710-26-000049) |url=https://www.sec.gov/Archives/edgar/data/1664710/000166471026000049/kros-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-03}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Keros Therapeutics overview